echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Full coverage of the purchase of coronary balloon belts during the year!

    Full coverage of the purchase of coronary balloon belts during the year!

    • Last Update: 2021-06-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical News, June 1st, May 26, 2021), Shanghai Sunshine Medical Purchasing Network published the "Notice on Carrying out Shanghai Municipality's Centralized Procurement of Coronary Balloon Medical Consumables".
    The types of centralized purchases this time are fast-exchange coronary balloon dilatation catheters and coronary balloon drug-coated catheters.
    All medical insurance designated medical institutions in this city that require the use of coronary balloon medical consumables are required to participate.
     
    This centralized purchase with volume will implement price linkage based on the link between volume and price.
    The agreed purchase volume is the purchase demand reported by medical institutions that have the use of coronary balloon medical consumables in this city.
    The purchase agreement is signed for the first time for one year.
    When the purchase agreement is renewed, the agreed purchase amount shall in principle be no less than the agreed purchase amount of the selected product in the previous year (the agreement period is less than one year, which shall be determined in proportion).
     
    NO.
    1
     
    Declaring products need to obtain the city's unified code
     
    80 products listed
     
    The documents show that the declared products should belong to the scope of purchased varieties and obtain a valid domestic medical device registration certificate, and have obtained the city's unified code before April 15, 2021.
    This centralized purchase with quantity is declared with the unified code of this city as the purchase unit, and the price of the same purchase unit is the same.
     
      According to the "Agreement Procurement Volume and 2020 "Sunshine Procurement Platform" Procurement Volume" attached to the document , 80 products (36 domestically produced and 44 imported) from 30 companies meet the application requirements.
     
      Among them, there are 74 rapid-exchange coronary balloon dilatation catheters, with a total contracted purchase of 108,960; coronary balloon drug-coated catheters involve 6 products, with a total contracted purchase of 6911.
     
      However, 12 of these 80 products have no contractual purchase volume.
    In terms of the number of qualified products of each company, Yeju Medical (8), Kossel (7), Abbott (6), Poco (5), Terumo (5) and other companies have an advantage .
     
      Related production (general agency) companies maintain information on each product, fill in the selected prices of all provincial centralized purchases in the country, and classify the characteristics of the rapid exchange coronary balloon dilatation catheter (semi-compliant and non-compliant) .
    Failure to fill in the product information and price as required will be directly included in the record product.
     
     
      NO.
    2
     
      Purchasing volume according to the agreement and
     
      Determine the selected product with the selected price in other provinces (cities) with quantity
     
      The determination of the selected product is mainly determined by two factors.
    First, see whether there is a price selected for centralized purchases from other provinces (cities); if there is, the selected price from other provinces and cities is the selection basis; if there is no, the price comparison of the same manufacturer is the basis; then look at the agreement.
    The level of procurement volume and platform procurement volume in 2020, low procurement volume requires more concessions in price.
    Among them, the median price, highest price, price ratio coefficient (determined by the median price of the effective bargaining of the city’s "Sunshine Purchasing Platform" corresponding to each product of the same brand within the scope of the purchase variety) related to volume procurement can be found in the system Inquiry.
     
      The rules for declared price are shown in the figure below:
     
     
      If the product requested by the medical institution is in the selected range, the corresponding purchase demand is included in the agreed purchase volume of the selected product.
    If it is not in the selected range, the corresponding purchase demand is regarded as the amount to be allocated, and the medical institution will select the product Select and determine the purchase amount.
     
      The declared price does not comply with the above-mentioned selection rules and the newly-obtained city's medical device unified code is included in the record product, and the medical insurance designated medical institutions and supply companies independently negotiate and purchase.
    The price must also comply with the current city's current medical device online bargaining regulations.
    Recorded products are included in the key monitoring list.
     
      NO.
    3
     
      The State Council requires that within the year
     
      Full coverage of provinces for procurement of coronary balloons
     
      From May 11th to 12th, the National Medical Insurance Administration held the "National Medical Centralized Procurement Policy and Practical Training Course" in Nanning, Guangxi .
    The meeting provided extremely clear guidance on the next step of mass procurement.
    Regarding medical consumables, focus on the following aspects:
     
      ● This year, the centralized procurement of medical consumables will focus on orthopaedics.
    The state plans to collect joints and spine collectively.
    Local governments can focus on trauma, medical transportation, artificial bone, and bone cement.
     
      ● At present, one province (Anhui) for coronary balloons and two provinces (Hubei, Zhejiang) for intraocular lenses have not carried out centralized procurement.
    It is recommended to achieve full coverage in all provinces within the year to consolidate the results of centralized procurement of cardiology and ophthalmology.
    For dental implants and drug balloons, interested provinces are requested to take the lead in making alliance purchases, and relevant provinces actively participate.
     
      ● At the meeting, in response to the needs of the situation, the results of the collection of new crown nucleic acid and antibody reagents were introduced, and the water content of IVD reagents was emphasized.
    It is recommended that all provinces give priority to consideration.
     
      According to the Huazhao Device Network, there are currently 9 negotiations for coronary balloons nationwide, including 4 alliance procurements and 5 provincial procurements.
    In addition, Hunan, Fujian, and Shanghai related procurement documents have been issued, and only left Anhui has yet to say anything.
    Judging from the procurement results, the decline in negotiations has shown a gradual upward trend.
    In the last few purchases of coronary balloons, the average decline has been basically around 90% (see the figure below).
    Under the national order, the next few places that have not implemented the procurement of coronary balloons must respond quickly, and the price level may continue to fall.
     
      Figure: A summary of the distribution and decline of the volume of coronary balloons purchased in various provinces (cities, districts) across the country
      Medical News, June 1st, May 26, 2021), Shanghai Sunshine Medical Purchasing Network published the "Notice on Carrying out Shanghai Municipality's Centralized Procurement of Coronary Balloon Medical Consumables".
    The types of centralized purchases this time are fast-exchange coronary balloon dilatation catheters and coronary balloon drug-coated catheters.
    All medical insurance designated medical institutions in this city that require the use of coronary balloon medical consumables are required to participate.
     
      This centralized purchase with volume will implement price linkage based on the link between volume and price.
    The agreed purchase volume is the purchase demand reported by medical institutions that have the use of coronary balloon medical consumables in this city.
    The purchase agreement is signed for the first time for one year.
    When the purchase agreement is renewed, the agreed purchase amount shall in principle be no less than the agreed purchase amount of the selected product in the previous year (the agreement period is less than one year, which shall be determined in proportion).
     
      NO.
    1
     
      Declaring products need to obtain the city's unified code
     
      80 products listed
     
      The documents show that the declared products should belong to the scope of purchased varieties and obtain a valid domestic medical device registration certificate, and have obtained the city's unified code before April 15, 2021.
    This centralized purchase with quantity is declared with the unified code of this city as the purchase unit, and the price of the same purchase unit is the same.
     
      According to the "Agreement Procurement Volume and 2020 "Sunshine Procurement Platform" Procurement Volume" attached to the document , 80 products (36 domestically produced and 44 imported) from 30 companies meet the application requirements.
     
      Among them, there are 74 rapid-exchange coronary balloon dilatation catheters, with a total contracted purchase of 108,960; coronary balloon drug-coated catheters involve 6 products, with a total contracted purchase of 6911.
     
      However, 12 of these 80 products have no contractual purchase volume.
    In terms of the number of qualified products of each company, Yeju Medical (8), Kossel (7), Abbott (6), Poco (5), Terumo (5) and other companies have an advantage .
     
      Related production (general agency) companies maintain information on each product, fill in the selected prices of all provincial centralized purchases in the country, and classify the characteristics of the rapid exchange coronary balloon dilatation catheter (semi-compliant and non-compliant) .
    Failure to fill in the product information and price as required will be directly included in the record product.
     
     
      NO.
    2
     
      Purchasing volume according to the agreement and
     
      Determine the selected product with the selected price in other provinces (cities) with quantity
     
      The determination of the selected product is mainly determined by two factors.
    First, see whether there is a price selected for centralized purchases from other provinces (cities); if there is, the selected price from other provinces and cities is the selection basis; if there is no, the price comparison of the same manufacturer is the basis; then look at the agreement.
    The level of procurement volume and platform procurement volume in 2020, low procurement volume requires more concessions in price.
    Among them, the median price, highest price, price ratio coefficient (determined by the median price of the effective bargaining of the city’s "Sunshine Purchasing Platform" corresponding to each product of the same brand within the scope of the purchase variety) related to volume procurement can be found in the system Inquiry.
     
      The rules for declared price are shown in the figure below:
     
     
      If the product requested by the medical institution is in the selected range, the corresponding purchase demand is included in the agreed purchase volume of the selected product.
    If it is not in the selected range, the corresponding purchase demand is regarded as the amount to be allocated, and the medical institution will select the product Select and determine the purchase amount.
     
      The declared price does not comply with the above-mentioned selection rules and the newly-obtained city's medical device unified code is included in the record product, and the medical insurance designated medical institutions and supply companies independently negotiate and purchase.
    The price must also comply with the current city's current medical device online bargaining regulations.
    Recorded products are included in the key monitoring list.
     
      NO.
    3
     
      The State Council requires that within the year
     
      Full coverage of provinces for procurement of coronary balloons
     
      From May 11th to 12th, the National Medical Insurance Administration held the "National Medical Centralized Procurement Policy and Practical Training Course" in Nanning, Guangxi .
    The meeting provided extremely clear guidance on the next step of mass procurement.
    Regarding medical consumables, focus on the following aspects:
     
      ● This year, the centralized procurement of medical consumables will focus on orthopaedics.
    The state plans to collect joints and spine collectively.
    Local governments can focus on trauma, medical transportation, artificial bone, and bone cement.
     
      ● At present, one province (Anhui) for coronary balloons and two provinces (Hubei, Zhejiang) for intraocular lenses have not carried out centralized procurement.
    It is recommended to achieve full coverage in all provinces within the year to consolidate the results of centralized procurement of cardiology and ophthalmology.
    For dental implants and drug balloons, interested provinces are requested to take the lead in making alliance purchases, and relevant provinces actively participate.
     
      ● At the meeting, in response to the needs of the situation, the results of the collection of new crown nucleic acid and antibody reagents were introduced, and the water content of IVD reagents was emphasized.
    It is recommended that all provinces give priority to consideration.
     
      According to the Huazhao Device Network, there are currently 9 negotiations for coronary balloons nationwide, including 4 alliance procurements and 5 provincial procurements.
    In addition, Hunan, Fujian, and Shanghai related procurement documents have been issued, and only left Anhui has yet to say anything.
    Judging from the procurement results, the decline in negotiations has shown a gradual upward trend.
    In the last few purchases of coronary balloons, the average decline has been basically around 90% (see the figure below).
    Under the national order, the next few places that have not implemented the procurement of coronary balloons must respond quickly, and the price level may continue to fall.
     
      Figure: A summary of the distribution and decline of the volume of coronary balloons purchased in various provinces (cities, districts) across the country
      Medical News, June 1st, May 26, 2021), Shanghai Sunshine Medical Purchasing Network published the "Notice on Carrying out Shanghai Municipality's Centralized Procurement of Coronary Balloon Medical Consumables".
    The types of centralized purchases this time are fast-exchange coronary balloon dilatation catheters and coronary balloon drug-coated catheters.
    All medical insurance designated medical institutions in this city that require the use of coronary balloon medical consumables are required to participate.
     
      This centralized purchase with volume will implement price linkage based on the link between volume and price.
    The agreed purchase volume is the purchase demand reported by medical institutions that have the use of coronary balloon medical consumables in this city.
    The purchase agreement is signed for the first time for one year.
    When the purchase agreement is renewed, the agreed purchase amount shall in principle be no less than the agreed purchase amount of the selected product in the previous year (the agreement period is less than one year, which shall be determined in proportion).
     
      NO.
    1
      NO.
    1
     
      Declaring products need to obtain the city's unified code
      Declaring products need to obtain the city's unified code
     
      80 products listed
      80 products listed
     
      The documents show that the declared products should belong to the scope of purchased varieties and obtain a valid domestic medical device registration certificate, and have obtained the city's unified code before April 15, 2021.
    This centralized purchase with quantity is declared with the unified code of this city as the purchase unit, and the price of the same purchase unit is the same.
    Medical equipment medical equipment medical equipment
     
      According to the "Agreement Procurement Volume and 2020 "Sunshine Procurement Platform" Procurement Volume" attached to the document , 80 products (36 domestically produced and 44 imported) from 30 companies meet the application requirements.
    Enterprise business enterprise
     
      Among them, there are 74 rapid-exchange coronary balloon dilatation catheters, with a total contracted purchase of 108,960; coronary balloon drug-coated catheters involve 6 products, with a total contracted purchase of 6911.
    Procurement Procurement Procurement
     
      However, 12 of these 80 products have no contractual purchase volume.
    In terms of the number of qualified products of each company, Yeju Medical (8), Kossel (7), Abbott (6), Poco (5), Terumo (5) and other companies have an advantage .
     
      Related production (general agency) companies maintain information on each product, fill in the selected prices of all provincial centralized purchases in the country, and classify the characteristics of the rapid exchange coronary balloon dilatation catheter (semi-compliant and non-compliant) .
    Failure to fill in the product information and price as required will be directly included in the record product.
     
     
      NO.
    2
      NO.
    2
     
      Purchasing volume according to the agreement and
      Purchasing volume according to the agreement and
     
      Determine the selected product with the selected price in other provinces (cities) with quantity
      Determine the selected product with the selected price in other provinces (cities) with quantity
     
      The determination of the selected product is mainly determined by two factors.
    First, see whether there is a price selected for centralized purchases from other provinces (cities); if there is, the selected price from other provinces and cities is the selection basis; if there is no, the price comparison of the same manufacturer is the basis; then look at the agreement.
    The level of procurement volume and platform procurement volume in 2020, low procurement volume requires more concessions in price.
    Among them, the median price, highest price, price ratio coefficient (determined by the median price of the effective bargaining of the city’s "Sunshine Purchasing Platform" corresponding to each product of the same brand within the scope of the purchase variety) related to volume procurement can be found in the system Inquiry.
     
      The rules for declared price are shown in the figure below:
      The rules for declared price are shown in the figure below:
     
     
      If the product requested by the medical institution is in the selected range, the corresponding purchase demand is included in the agreed purchase volume of the selected product.
    If it is not in the selected range, the corresponding purchase demand is regarded as the amount to be allocated, and the medical institution will select the product Select and determine the purchase amount.
     
      The declared price does not comply with the above-mentioned selection rules and the newly-obtained city's medical device unified code is included in the record product, and the medical insurance designated medical institutions and supply companies independently negotiate and purchase.
    The price must also comply with the current city's current medical device online bargaining regulations.
    Recorded products are included in the key monitoring list.
     
      NO.
    3
      NO.
    3
     
      The State Council requires that within the year
      The State Council requires that within the year
     
      Full coverage of provinces for procurement of coronary balloons
      Full coverage of provinces for procurement of coronary balloons
     
      From May 11th to 12th, the National Medical Insurance Administration held the "National Medical Centralized Procurement Policy and Practical Training Course" in Nanning, Guangxi .
    The meeting provided extremely clear guidance on the next step of mass procurement.
    Regarding medical consumables, focus on the following aspects:
    Medicine Medicine Medicine
     
      ● This year, the centralized procurement of medical consumables will focus on orthopaedics.
    The state plans to collect joints and spine collectively.
    Local governments can focus on trauma, medical transportation, artificial bone, and bone cement.
     
      ● At present, one province (Anhui) for coronary balloons and two provinces (Hubei, Zhejiang) for intraocular lenses have not carried out centralized procurement.
    It is recommended to achieve full coverage in all provinces within the year to consolidate the results of centralized procurement of cardiology and ophthalmology.
    For dental implants and drug balloons, interested provinces are requested to take the lead in making alliance purchases, and relevant provinces actively participate.
     
      ● At the meeting, in response to the needs of the situation, the results of the collection of new crown nucleic acid and antibody reagents were introduced, and the water content of IVD reagents was emphasized.
    It is recommended that all provinces give priority to consideration.
     
      According to the Huazhao Device Network, there are currently 9 negotiations for coronary balloons nationwide, including 4 alliance procurements and 5 provincial procurements.
    In addition, Hunan, Fujian, and Shanghai related procurement documents have been issued, and only left Anhui has yet to say anything.
    Judging from the procurement results, the decline in negotiations has shown a gradual upward trend.
    In the last few purchases of coronary balloons, the average decline has been basically around 90% (see the figure below).
    Under the national order, the next few places that have not implemented the procurement of coronary balloons must respond quickly, and the price level may continue to fall.
     
      Figure: A summary of the distribution and decline of the volume of coronary balloons purchased in various provinces (cities, districts) across the country
      
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.